ATE242632T1 - Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen - Google Patents
Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomenInfo
- Publication number
- ATE242632T1 ATE242632T1 AT98915378T AT98915378T ATE242632T1 AT E242632 T1 ATE242632 T1 AT E242632T1 AT 98915378 T AT98915378 T AT 98915378T AT 98915378 T AT98915378 T AT 98915378T AT E242632 T1 ATE242632 T1 AT E242632T1
- Authority
- AT
- Austria
- Prior art keywords
- betulinic acid
- treat
- acid derivatives
- prevent melanoma
- composition
- Prior art date
Links
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical class C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 title abstract 3
- 201000001441 melanoma Diseases 0.000 title abstract 2
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 abstract 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 abstract 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 abstract 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000004614 tumor growth Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/858,011 US5869535A (en) | 1995-03-21 | 1997-05-16 | Method and composition for selectively inhibiting melanoma |
| PCT/US1998/007007 WO1998051293A1 (en) | 1997-05-16 | 1998-04-06 | Use of betulinic acid derivatives for the treatment and prevention of melanoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE242632T1 true ATE242632T1 (de) | 2003-06-15 |
Family
ID=25327234
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98915378T ATE242632T1 (de) | 1997-05-16 | 1998-04-06 | Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US5869535A (de) |
| EP (2) | EP1266658A3 (de) |
| AT (1) | ATE242632T1 (de) |
| CA (1) | CA2289686A1 (de) |
| DE (1) | DE69815527T2 (de) |
| DK (1) | DK0981341T3 (de) |
| ES (1) | ES2201478T3 (de) |
| PT (1) | PT981341E (de) |
| WO (1) | WO1998051293A1 (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962527A (en) * | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
| US6228850B1 (en) * | 1997-09-30 | 2001-05-08 | Dabur Research Foundation | Antiangiogenic activity of betulinic acid and its derivatives |
| US6670345B1 (en) | 1997-09-30 | 2003-12-30 | Dabur Research Foundation | Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid |
| US6048847A (en) * | 1997-09-30 | 2000-04-11 | Dabur Research Foundation | Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this |
| US6214814B1 (en) * | 1998-03-18 | 2001-04-10 | Dabur Research Foundation | Use of betulinic acid derivatives for inhibiting cancer growth |
| TWI227136B (en) * | 1998-05-21 | 2005-02-01 | Smithkline Beecham Corp | Novel pharmaceutical composition for the prevention and/or treatment of cancer |
| US6369109B1 (en) | 1998-10-28 | 2002-04-09 | Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts | Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor |
| WO2000046235A1 (en) * | 1998-11-18 | 2000-08-10 | Dabur Research Foundation | Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| US6303589B1 (en) | 1998-12-08 | 2001-10-16 | Micro Flo Company | Pentacyclic triterpenes |
| DE69917684T2 (de) * | 1999-09-09 | 2005-07-21 | Dabur Research Foundation, Sahibabad | Betulinsäure-derivate mit antiangiogener wirkung, verfahren zur herstellung solcher derivate und deren verwendung für die behandlung tumorassoziierter angiogenese |
| GB2362648A (en) | 2000-05-23 | 2001-11-28 | Univerzita Palackeho V Olomouc | Triterpenoid derivatives |
| NZ524087A (en) * | 2000-08-18 | 2004-08-27 | Univ Illinois | Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV |
| KR100445683B1 (ko) * | 2001-05-02 | 2004-08-21 | 김송배 | 신규의 루판 유도체, 그의 제조방법 및 그를 포함하는항암제 |
| US7488722B2 (en) * | 2001-05-11 | 2009-02-10 | University Of Ottawa | Anxiolytic Marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods |
| AU2002367429A1 (en) * | 2001-12-28 | 2003-07-24 | The Nisshin Oillio, Ltd. | Apoptosis inductor |
| US7026305B2 (en) * | 2003-04-14 | 2006-04-11 | Meharry Medical College | Anti-HIV agents with dual sites of action |
| US20080227762A1 (en) * | 2004-03-02 | 2008-09-18 | Wisconsin Alumni Research Foundation | Lupeol anti-tumor agent and uses thereof |
| US20060019934A1 (en) * | 2004-05-20 | 2006-01-26 | Saxena Brij B | Anti-HIV-1 activity of betulinol derivatives |
| CA2580076A1 (en) * | 2004-09-10 | 2006-03-23 | Cornell Research Foundation, Inc | Betulinol derivatives as anti-hiv agents |
| US20060252733A1 (en) * | 2005-04-07 | 2006-11-09 | Novelix Pharmaceuticals, Inc. | Betulin, betulin derivatives, betulinic acid and betulinic acid derivatives as novel therapeutics in the treatment of disease of lipid and/or glucose metabolism |
| CA2609280A1 (en) * | 2005-06-22 | 2007-01-04 | Myriad Genetics, Inc. | Antiviral compounds |
| ZA200805703B (en) * | 2005-12-16 | 2009-10-28 | Panacos Pharmaceuticals Inc | Preparation of pharmaceutical salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid |
| DE102006008074B4 (de) * | 2006-02-22 | 2013-08-14 | RUHR-UNIVERSITäT BOCHUM | Behandlung von Krebs mit Geruchsrezeptor-Liganden |
| FI121468B (fi) * | 2006-06-07 | 2010-11-30 | Valtion Teknillinen | Betuliiniperäiset yhdisteet antimikrobisina aineina |
| WO2008115281A2 (en) * | 2006-10-16 | 2008-09-25 | Myriad Genetics, Inc. | Compounds for treating viral infections |
| WO2012106190A1 (en) | 2011-01-31 | 2012-08-09 | Bristol-Myers Squibb Company | C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| US9276602B1 (en) * | 2009-12-16 | 2016-03-01 | Syntropy Systems, Llc | Conversion of a discrete-time quantized signal into a continuous-time, continuously variable signal |
| US8802661B2 (en) | 2010-06-04 | 2014-08-12 | Bristol-Myers Squibb Company | C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors |
| ES2612452T3 (es) | 2010-06-04 | 2017-05-17 | VIIV Healthcare UK (No.5) Limited | Derivados de ácido betulínico C-3 modificados como inhibidores de la maduración del VIH |
| PT2670764E (pt) | 2011-01-31 | 2015-11-20 | Bristol Myers Squibb Co | C-28 aminas de derivados de ácido betulínico c-3 modificado como inibidores de maturação de vih |
| ES2611727T3 (es) | 2011-09-21 | 2017-05-10 | VIIV Healthcare UK (No.5) Limited | Derivados de ácido betulínico novedosos con actividad antivírica |
| US8906889B2 (en) | 2012-02-15 | 2014-12-09 | Bristol-Myers Squibb Company | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| US9808011B2 (en) | 2014-12-15 | 2017-11-07 | Biovectra Inc. | Pentacyclic triterpene compounds and uses thereof |
| PL227790B1 (pl) | 2015-08-13 | 2018-01-31 | Slaski Univ Medyczny W Katowicach | Fosfoniany acetylenowych pochodnych betuliny o działaniu przeciwnowotworowym, sposób ich wytwarzania i zastosowanie. |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01143832A (ja) * | 1987-12-01 | 1989-06-06 | Toa Nenryo Kogyo Kk | 制癌剤 |
| FR2683531B1 (fr) * | 1991-11-13 | 1993-12-31 | Rhone Poulenc Rorer Sa | Nouveaux derives du lupane, leur preparation et les compositions pharmaceutiques qui les contiennent. |
| FR2705097B1 (fr) * | 1993-05-11 | 1995-08-04 | Rhone Poulenc Rorer Sa | Nouveaux dérivés du lupane, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| US5643884A (en) * | 1993-08-09 | 1997-07-01 | Glycomed Incorporated | Lupane triterpenoid derivatives |
| US5658947A (en) * | 1995-03-21 | 1997-08-19 | Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma using betalinic acid |
| US5962527A (en) * | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
| US5679828A (en) * | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| DE19532006A1 (de) * | 1995-08-31 | 1997-03-06 | Thomas Samland | Medizinisches bzw. kosmetisches Präparat zur Vermeidung bzw. Abbau von Hautkrebs |
| WO1998032443A1 (de) * | 1997-01-24 | 1998-07-30 | Marigen S.A. | Ultramikroemulsionen aus spontan dispergierbaren konzentraten enthaltend antitumoral, antiviral und antiparasitär wirksame ester von pentacyclischen triterpenen |
| WO2000046235A1 (en) | 1998-11-18 | 2000-08-10 | Dabur Research Foundation | Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| WO2000059492A2 (en) | 1999-04-07 | 2000-10-12 | Washington State University Research Foundation | Anti-tumor activity of vitamin e, cholesterol, taxol and betulinic acid derivatives |
| CN1450900A (zh) | 2000-07-31 | 2003-10-22 | 日清奥利友株式会社 | 抗肿瘤剂 |
-
1997
- 1997-05-16 US US08/858,011 patent/US5869535A/en not_active Expired - Fee Related
-
1998
- 1998-04-06 WO PCT/US1998/007007 patent/WO1998051293A1/en active IP Right Grant
- 1998-04-06 AT AT98915378T patent/ATE242632T1/de not_active IP Right Cessation
- 1998-04-06 CA CA002289686A patent/CA2289686A1/en not_active Abandoned
- 1998-04-06 DK DK98915378T patent/DK0981341T3/da active
- 1998-04-06 ES ES98915378T patent/ES2201478T3/es not_active Expired - Lifetime
- 1998-04-06 EP EP02019173A patent/EP1266658A3/de not_active Withdrawn
- 1998-04-06 EP EP98915378A patent/EP0981341B1/de not_active Expired - Lifetime
- 1998-04-06 DE DE69815527T patent/DE69815527T2/de not_active Expired - Fee Related
- 1998-04-06 PT PT98915378T patent/PT981341E/pt unknown
- 1998-11-10 US US09/189,698 patent/US6225353B1/en not_active Expired - Fee Related
-
2000
- 2000-08-09 US US09/635,385 patent/US6495600B1/en not_active Expired - Fee Related
-
2002
- 2002-12-12 US US10/317,361 patent/US7414042B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US7414042B2 (en) | 2008-08-19 |
| US5869535A (en) | 1999-02-09 |
| DE69815527D1 (de) | 2003-07-17 |
| DE69815527T2 (de) | 2004-05-13 |
| EP0981341A1 (de) | 2000-03-01 |
| US20030181429A1 (en) | 2003-09-25 |
| EP1266658A3 (de) | 2004-05-26 |
| DK0981341T3 (da) | 2003-09-22 |
| EP0981341B1 (de) | 2003-06-11 |
| EP1266658A2 (de) | 2002-12-18 |
| WO1998051293A1 (en) | 1998-11-19 |
| PT981341E (pt) | 2003-10-31 |
| ES2201478T3 (es) | 2004-03-16 |
| US6225353B1 (en) | 2001-05-01 |
| US6495600B1 (en) | 2002-12-17 |
| CA2289686A1 (en) | 1998-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE242632T1 (de) | Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen | |
| DE69828042D1 (de) | Verfahren und zusammensetzung zur behandlung von krebs | |
| ATE250576T1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| MX9302932A (es) | Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa. | |
| MX9304638A (es) | Composicion para tratar e inhibir las ulceras gastricas y duodenales. | |
| ATE399547T1 (de) | Verwendung von cyclooxygenase-2 inhibitoren zur behandlung und vorbeugung von neoplasia | |
| AU6998787A (en) | Transglutaminase inhibitors | |
| DE60013266D1 (de) | Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion | |
| DK0701546T3 (da) | Aromatiske acetylchlolinesteraseinhibitorer | |
| ATE156359T1 (de) | Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis | |
| DE69707372T2 (de) | Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne | |
| DE69808099D1 (de) | Substituierte 6-alkylphenanthridine | |
| ATE206052T1 (de) | Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten | |
| MX9304626A (es) | Derivados heterociclicos utiles en el tratamiento de enfermedades cardiovasculares. | |
| BR9203266A (pt) | Composto,formulacao farmaceutica,processo para inibir 5alfa-reductase,processos para tratar hiperplasia benigna da prostata,seborreia e alopecia androgenica | |
| DE69429013D1 (de) | Verwendung von dimeticon zur behandlung der konstipation | |
| NO990436D0 (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
| ATE204167T1 (de) | Antikonvulsive derivate zur behandlung von psoriasis | |
| PT971714E (pt) | Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia | |
| ATE292970T1 (de) | Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden | |
| ATE193537T1 (de) | Phosphorylierte derivate von verbindungen mit antiinflammatorischen oder analgetischer wirkung | |
| MY130771A (en) | 3-azabicyclo [3.1.0] hexane derivatives useful in therapy. | |
| UA32151A (uk) | Склад для лікування псоріазу | |
| DE69822628D1 (de) | Zur vorbeugung oder behandlung von östrogenabhängigen krankheiten nützliche pyrrolo[2.1.5-cd]indolizin-derivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0981341 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |